Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
2002· article· en· The Lancet· Medicine
affno abstract
1,591
citations
Works
Every work in the frame. Each row carries the routes that admitted it, because a frame that forgets how it found something cannot be audited.
Route
Field
Type
Language
Year range
to
Screen consensus
Sort
Flags
Screening evidence
Direct labels are sparse and unvalidated. Missing labels are unknown.
1 filter active
2,133 workspage 1 of 86
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
2014· article· en· The Lancet Oncology· Medicine
afffundno abstract
1,174
citations
A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma
2008· review· en· Cancer· Medicine
aff
982
citations
870
citations
857
citations
PAX3-FKHR and PAX7-FKHR Gene Fusions Are Prognostic Indicators in Alveolar Rhabdomyosarcoma: A Report From the Children’s Oncology Group
2002· article· en· Journal of Clinical Oncology· Medicine
aff
741
citations
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
2019· article· en· European Journal of Cancer· Medicine
aff
726
citations
Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma
2005· article· en· Radiotherapy and Oncology· Medicine
affno abstract
708
citations
MDM2 and CDK4 Immunostainings Are Useful Adjuncts in Diagnosing Well-Differentiated and Dedifferentiated Liposarcoma Subtypes
2005· article· en· The American Journal of Surgical Pathology· Medicine
aff
644
citations
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25
2001· article· en· Oncogene· Medicine
affno abstract
622
citations
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
2012· article· en· The Lancet Oncology· Medicine
fundno affno abstract
588
citations
Molecular characterisation of soft tissue tumours: a gene expression study
2002· article· en· The Lancet· Medicine
affno abstract
580
citations
Sarcoma classification by DNA methylation profiling
2021· article· en· Nature Communications· Medicine
fundno aff
547
citations
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
2016· article· en· The Lancet Oncology· Medicine
aff
541
citations
518
citations
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
2020· article· en· The Lancet Oncology· Medicine
affno abstract
482
citations
Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis
2016· article· en· The Lancet Oncology· Medicine
affno abstract
478
citations
Integrated Molecular Characterization of Uterine Carcinosarcoma
2017· article· en· Cancer Cell· Medicine
affno abstract
444
citations
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
2015· article· en· Journal of Clinical Oncology· Medicine
fundno aff
421
citations
Analysis of Prognostic Factors in Patients With Nonmetastatic Rhabdomyosarcoma Treated on Intergroup Rhabdomyosarcoma Studies III and IV: The Children's Oncology Group
2006· article· en· Journal of Clinical Oncology· Medicine
aff
392
citations
A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma
2001· article· en· European Journal of Cancer· Medicine
affno abstract
378
citations
TLE1 as a Diagnostic Immunohistochemical Marker for Synovial Sarcoma Emerging From Gene Expression Profiling Studies
2007· article· en· The American Journal of Surgical Pathology· Medicine
aff
350
citations
Sox10 and S100 in the Diagnosis of Soft-tissue Neoplasms
2012· article· en· Applied immunohistochemistry & molecular morphology· Medicine
aff
347
citations
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment
2014· article· en· Annals of Oncology· Medicine
affno abstract
333
citations
Identification of a PAX-FKHR Gene Expression Signature that Defines Molecular Classes and Determines the Prognosis of Alveolar Rhabdomyosarcomas
2006· article· en· Cancer Research· Medicine
aff
310
citations